Indaptus Therapeutics Inc...

0.50
-0.02 (-2.91%)
At close: Apr 02, 2025, 3:57 PM
0.52
4.60%
After-hours: Apr 02, 2025, 07:56 PM EDT

Indaptus Therapeutics Statistics

Share Statistics

Indaptus Therapeutics has 14.43M shares outstanding. The number of shares has increased by 68.98% in one year.

Shares Outstanding 14.43M
Shares Change (YoY) 68.98%
Shares Change (QoQ) 20.1%
Owned by Institutions (%) 6.71%
Shares Floating 11.61M
Failed to Deliver (FTD) Shares 2.52K
FTD / Avg. Volume 0.6%

Short Selling Information

The latest short interest is 138.7K, so 1.15% of the outstanding shares have been sold short.

Short Interest 138.7K
Short % of Shares Out 1.15%
Short % of Float 1.5%
Short Ratio (days to cover) 0.54

Valuation Ratios

The PE ratio is -0.52 and the forward PE ratio is -0.65. Indaptus Therapeutics's PEG ratio is 0.04.

PE Ratio -0.52
Forward PE -0.65
PS Ratio 0
Forward PS 0.1
PB Ratio 2
P/FCF Ratio -0.64
PEG Ratio 0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Indaptus Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.02.

Current Ratio 1.95
Quick Ratio 1.95
Debt / Equity 0.02
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.15M
Employee Count 7
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -77.78% in the last 52 weeks. The beta is 1.11, so Indaptus Therapeutics's price volatility has been higher than the market average.

Beta 1.11
52-Week Price Change -77.78%
50-Day Moving Average 0.8
200-Day Moving Average 1.3
Relative Strength Index (RSI) 25.37
Average Volume (20 Days) 420.77K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -15.37M
Net Income -15.02M
EBITDA -15.37M
EBIT n/a
Earnings Per Share (EPS) -1.61
Full Income Statement

Balance Sheet

The company has 5.79M in cash and 84.16K in debt, giving a net cash position of 5.7M.

Cash & Cash Equivalents 5.79M
Total Debt 84.16K
Net Cash 5.7M
Retained Earnings -60.44M
Total Assets 7.34M
Working Capital 3.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.32M and capital expenditures 0, giving a free cash flow of -12.32M.

Operating Cash Flow -12.32M
Capital Expenditures 0
Free Cash Flow -12.32M
FCF Per Share -1.32
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

INDP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for INDP is $8.5, which is 1534.6% higher than the current price. The consensus rating is "Buy".

Price Target $8.5
Price Target Difference 1534.6%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Jul 27, 2021. It was a backward split with a ratio of 1:4.

Last Split Date Jul 27, 2021
Split Type backward
Split Ratio 1:4

Scores

Altman Z-Score -16.6
Piotroski F-Score 1